A new trading day began on Friday, with Larimar Therapeutics Inc (NASDAQ: LRMR) stock price up 7.31% from the previous day of trading, before settling in for the closing price of $6.02. LRMR’s price has ranged from $3.34 to $13.68 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -44.76%. With a float of $37.01 million, this company’s outstanding shares have now reached $63.81 million.
Considering the fact that the conglomerate employs 42 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Larimar Therapeutics Inc (LRMR) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Larimar Therapeutics Inc is 42.00%, while institutional ownership is 60.93%. The most recent insider transaction that took place on Feb 16 ’24, was worth 499,998. In this transaction Director of this company bought 57,208 shares at a rate of $8.74, taking the stock ownership to the 564,798 shares. Before that another transaction happened on Feb 16 ’24, when Company’s Director bought 4,290,617 for $8.74, making the entire transaction worth $37,499,993. This insider now owns 6,151,406 shares in total.
Larimar Therapeutics Inc (LRMR) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -44.76% per share during the next fiscal year.
Larimar Therapeutics Inc (NASDAQ: LRMR) Trading Performance Indicators
Here are Larimar Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 13.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.15, a number that is poised to hit -0.32 in the next quarter and is forecasted to reach -1.61 in one year’s time.
Technical Analysis of Larimar Therapeutics Inc (LRMR)
Compared to the last year’s volume of 0.59 million, its volume of 0.71 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 41.91%. Additionally, its Average True Range was 0.52.
During the past 100 days, Larimar Therapeutics Inc’s (LRMR) raw stochastic average was set at 17.07%, which indicates a significant decrease from 77.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 67.17% in the past 14 days, which was lower than the 78.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.17, while its 200-day Moving Average is $7.92. Nevertheless, the first resistance level for the watch stands at $6.64 in the near term. At $6.81, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.13. If the price goes on to break the first support level at $6.15, it is likely to go to the next support level at $5.83. Should the price break the second support level, the third support level stands at $5.66.
Larimar Therapeutics Inc (NASDAQ: LRMR) Key Stats
With a market capitalization of 442.32 million, the company has a total of 63,807K Shares Outstanding. Currently, annual sales are 0 K while annual income is -36,950 K. The company’s previous quarter sales were 0 K while its latest quarter income was -15,500 K.
